|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
Counterfeit drugs are known to exist in both developed and developing
countries. However, the true extent of the problem is not really known,
since no global study has been carried out. A counterfeit drug is
designed to deceive – particularly if it is copied to make it look like
the original product – and if it comes from a supposedly legitimate
source, purchasers are unlikely to be suspicious.
Martin Dallas
at Essentra discusses how anti-counterfeiting and safety legislation –
together with technological progress and increasingly demanding consumer
requirements – are all contributing to a surge in innovative designs
within the pharma packaging sector (page 40). With the new EU Directive
on counterfeit medicines set to come into force in 2016, there are
significant demands on the industry to both verify authenticity and
demonstrate tamper evidence. As pharma has moved towards compact formats
for package inserts, this has necessitated major investment in new
technology to handle the printing and folding of larger format leaflets,
in order to accommodate the level of detail which ever-increasing
legislation brings.
Moving away from regulatory demands, other
innovations are also playing their part in meeting market requirements.
Dallas is confident, however, that with legislative measures and
packaging technology driving progress within the pharma sector, it is
possible to find the ideal solution to meet the needs of just about any customer – and their consumers.
One
approach in particular which addresses the issue of counterfeit
medicines is highlighted by Ian Lancaster at the International Hologram
Manufacturers Association (page 26). He discusses various solutions –
from holograms to packaging integrating QR codes, coding foils and
virtual identification. Lancaster concludes that one of the reasons for
the success of holograms has been the ability of manufacturers to adapt
them and constantly find new applications. He believes that we will see
more and more interesting developments for the technology over the
coming years, which will undoubtedly offer far-reaching benefits that
advance and expand the role of track and trace.
Of course, it is
no good having distinctive, unique labelling of products if they are
unable to be read and managed by computer systems during storage. This
is a concern that is outlined by Rafael Hernández at Honeywell Scanning
and Mobility (page 48). Freezing temperatures of -30°C not only affect
stored goods, but also all other materials used within the warehouse.
Mobile computers, scanners, printers and voice solutions must therefore
demonstrate exceptional resistance to the growing use of low-temperature
storage.
Hernández reveals how factors such as frost,
condensation, and even cold air can have significant deleterious effects
on the logistics of storage. He gives five tips on how to achieve the
right marriage between printers, devices and labels in the cold store.
Seamless tracking and tracing of goods is essential for a smooth and
efficient flow within the warehouse – and especially so in frozen
storage. The media used play an essential role here, and the most
successful solutions can, as ever, be obtained with the competence and
experience of a reliable provider.
Cold chain and counterfeiting
are just two of the important themes that we have addressed in this
issue of PMPS. In addition, we feature topical articles on pre-filled
syringes, medical device legislation in Japan, automation and blend
uniformity. Finally, make sure you don’t miss either of the interviews
from Air France-KLM-Martinair Cargo (page 46) and DHL (page 70).
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Rentschler Biopharma and Vetter Unveil Xpert Alliance
Laupheim and Ravensburg, Germany, Milford, MA, and Skokie, IL, USA,
March 29, 2022 – Rentschler Biopharma and Vetter, two globally operating
Contract Development and Manufacturing Organizations (CDMOs), announced
today that the companies are unveiling Xpert Alliance, a joint
visualization of their strategic collaboration. The visualization is
designed to “bring to life” this ongoing alliance and celebrate its
successful operation, delivering effective solutions to address clients’
changing and expanding needs in the area of complex biopharmaceuticals.
More info >> |
|
 |
White Papers |
 |
|
Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections
IBT Bioservices
Introduction
Staphylococcus aureus (SA) is a ubiquitous, formidable
Gram-positive pathogen associated with skin and soft tissue, as well as
lifethreatening systemic infections. SA is a leading cause of hospital- and
community-associated infections worldwide, affecting humans and animals. The
wide range of pathologies reflects the diverse abilities of this microbe to
escape the innate and adaptive immune response using virulence factors. Since
its first emergence in the 1960s methicillin-resistant SA (MRSA) has become
endemic in hospitals and healthcare settings worldwide. In the 1990s, community
associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a
major global challenge.
More info >> |
|
 |
Industry Events |
 |
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)
20-21 June 2022, Berlin, Germany
Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is
held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers
pharmaceutical companies, CMOs and CDMOs, governmental bodies together
with pharmaceutical equipment providers and service companies to discuss
the manufacturing and packaging processes of the pharmaceutical
industry. Among the participating companies are Bayer, Sandoz, Merck,
Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >> |
|
|
